{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T04:10:56Z","timestamp":1792987856933,"version":"4.5.0"},"reference-count":42,"publisher":"e-Century Publishing Corporation","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/zmal4724","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T02:07:16Z","timestamp":1716862036000},"page":"1690-1700","source":"Crossref","is-referenced-by-count":8,"title":["The effects of alfacalcidol combined with calcitonin in the treatment of osteoporosis and its influence on levels of inflammation"],"prefix":"10.62347","volume":"16","author":[{"given":"Ze","family":"Rui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.mcna.2020.06.004","article-title":"Osteoporosis in older adults","volume":"104","author":"Johnston","year":"2020","unstructured":"Johnston CB and Dagar M. Osteoporosis in older adults. Med Clin North Am 2020; 104: 873-884.","journal-title":"Med Clin North Am"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3390\/ijms21010349","article-title":"Senile osteoporosis: the involvement of differentiation and senescence of bone marrow stromal cells","volume":"21","author":"Qadir","year":"2020","unstructured":"Qadir A, Liang S, Wu Z, Chen Z, Hu L and Qian A. Senile osteoporosis: the involvement of differentiation and senescence of bone marrow stromal cells. Int J Mol Sci 2020; 21: 349.","journal-title":"Int J Mol Sci"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1097\/GRF.0000000000000572","article-title":"Bone health and osteoporosis prevention and treatment","volume":"63","author":"Munoz","year":"2020","unstructured":"Munoz M, Robinson K and Shibli-Rahhal A. Bone health and osteoporosis prevention and treatment. Clin Obstet Gynecol 2020; 63: 770-787.","journal-title":"Clin Obstet Gynecol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/jmwh.12954","article-title":"Clinical update on osteoporosis","volume":"64","author":"Anthamatten","year":"2019","unstructured":"Anthamatten A and Parish A. Clinical update on osteoporosis. J Midwifery Womens Health 2019; 64: 265-275.","journal-title":"J Midwifery Womens Health"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1093\/ajhp\/zxy022","article-title":"Abaloparatide: a new pharmacological option for osteoporosis","volume":"76","author":"Sleeman","year":"2019","unstructured":"Sleeman A and Clements JN. Abaloparatide: a new pharmacological option for osteoporosis. Am J Health Syst Pharm 2019; 76: 130-135.","journal-title":"Am J Health Syst Pharm"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1002\/jbmr.3757","article-title":"The prevalence of osteoporosis in China, a nationwide, multicenter DXA survey","volume":"34","author":"Zeng","year":"2019","unstructured":"Zeng Q, Li N, Wang Q, Feng J, Sun D, Zhang Q, Huang J, Wen Q, Hu R, Wang L, Ma Y, Fu X, Dong S and Cheng X. The prevalence of osteoporosis in China, a nationwide, multicenter DXA survey. J Bone Miner Res 2019; 34: 1789-1797.","journal-title":"J Bone Miner Res"},{"key":"ref6","unstructured":"Martiniakova M, Babikova M and Omelka R. Pharmacological agents and natural compounds: available treatments for osteoporosis. J Physiol Pharmacol 2020; 71."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"6564","DOI":"10.3390\/ijms22126564","article-title":"The influence of strontium on bone tissue metabolism and its application in osteoporosis treatment","volume":"22","author":"Kolodziejska","year":"2021","unstructured":"Kolodziejska B, Stepien N and Kolmas J. The influence of strontium on bone tissue metabolism and its application in osteoporosis treatment. Int J Mol Sci 2021; 22: 6564.","journal-title":"Int J Mol Sci"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.ecl.2013.02.007","article-title":"Diagnosis and treatment of osteoporosis in older adults","volume":"42","author":"Diab","year":"2013","unstructured":"Diab DL and Watts NB. Diagnosis and treatment of osteoporosis in older adults. Endocrinol Metab Clin North Am 2013; 42: 305-317.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1007\/s00774-020-01091-4","article-title":"Eldecalcitol is superior to alfacalcidol in maintaining bone mineral density in glucocorticoid-induced osteoporosis patients (e-GLORIA)","volume":"38","author":"Matsumoto","year":"2020","unstructured":"Matsumoto T, Yamamoto K, Takeuchi T, Tanaka Y, Tanaka S, Nakano T, Ito M, Tomomitsu T, Hirakawa A and Soen S. Eldecalcitol is superior to alfacalcidol in maintaining bone mineral density in glucocorticoid-induced osteoporosis patients (e-GLORIA). J Bone Miner Metab 2020; 38: 522-532.","journal-title":"J Bone Miner Metab"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s11657-022-01071-3","article-title":"Overview of the clinical efficacy and safety of eldecalcitol for the treatment of osteoporosis","volume":"17","author":"Cui","year":"2022","unstructured":"Cui L, Xia W, Yu C, Dong S and Pei Y. Overview of the clinical efficacy and safety of eldecalcitol for the treatment of osteoporosis. Arch Osteoporos 2022; 17: 74.","journal-title":"Arch Osteoporos"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"5012","DOI":"10.3390\/molecules27155012","article-title":"A multi-omics analysis reveals anti-osteoporosis mechanism of four components from crude and salt-processed achyranthes bidentata blume in ovariectomized rats","volume":"27","author":"Yin","year":"2022","unstructured":"Yin Y, Zhu F, Pan M, Bao J, Liu Q and Tao Y. A multi-omics analysis reveals anti-osteoporosis mechanism of four components from crude and salt-processed achyranthes bidentata blume in ovariectomized rats. Molecules 2022; 27: 5012.","journal-title":"Molecules"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Wu H, Lin XQ, Long Y and Wang J. Calcitonin gene-related peptide is potential therapeutic target of osteoporosis. Heliyon 2022; 8: e12288.","DOI":"10.1016\/j.heliyon.2022.e12288"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1039\/C9TB02049G","article-title":"A thermo-sensitive injectable hydroxypropyl chitin hydrogel for sustained salmon calcitonin release with enhanced osteogenesis and hypocalcemic effects","volume":"8","author":"Yu","year":"2020","unstructured":"Yu P, Xie J, Chen Y, Liu J, Liu Y, Bi B, Luo J, Li S, Jiang X and Li J. A thermo-sensitive injectable hydroxypropyl chitin hydrogel for sustained salmon calcitonin release with enhanced osteogenesis and hypocalcemic effects. J Mater Chem B 2020; 8: 270-281.","journal-title":"J Mater Chem B"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"534","DOI":"10.7326\/0003-4819-136-7-200204020-00011","article-title":"Acquired aplastic anemia","volume":"136","author":"Young","year":"2002","unstructured":"Young NS. Acquired aplastic anemia. Ann Intern Med 2002; 136: 534-546.","journal-title":"Ann Intern Med"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Young NS, Bacigalupo A and Marsh JC. Aplastic anemia: pathophysiology and treatment. Biol Blood Marrow Transplant 2010; 16 Suppl: S119-125.","DOI":"10.1016\/j.bbmt.2009.09.013"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1182\/bloodadvances.2021004345","article-title":"Approach to the diagnosis of aplastic anemia","volume":"5","author":"DeZern","year":"2021","unstructured":"DeZern AE and Churpek JE. Approach to the diagnosis of aplastic anemia. Blood Adv 2021; 5: 2660-2671.","journal-title":"Blood Adv"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s11864-017-0511-z","article-title":"Diagnosis and treatment of aplastic anemia","volume":"18","author":"SA","year":"2017","unstructured":"Peslak SA, Olson T and Babushok DV. Diagnosis and treatment of aplastic anemia. Curr Treat Options Oncol 2017; 18: 70.","journal-title":"Curr Treat Options Oncol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s00198-021-06261-2","article-title":"Effect of the duration of previous osteoporosis treatment on the effect of romosozumab treatment","volume":"33","author":"Tominaga","year":"2022","unstructured":"Tominaga A, Wada K, Okazaki K, Nishi H, Terayama Y, Kodama Y and Kato Y. Effect of the duration of previous osteoporosis treatment on the effect of romosozumab treatment. Osteoporos Int 2022; 33: 1265-1273.","journal-title":"Osteoporos Int"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1186\/s13018-021-02678-x","article-title":"Effect of drugs on bone mineral density in postmenopausal osteoporosis: a Bayesian network meta-analysis","volume":"16","author":"Migliorini","year":"2021","unstructured":"Migliorini F, Maffulli N, Colarossi G, Eschweiler J, Tingart M and Betsch M. Effect of drugs on bone mineral density in postmenopausal osteoporosis: a Bayesian network meta-analysis. J Orthop Surg Res 2021; 16: 533.","journal-title":"J Orthop Surg Res"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"D’Alessandro R, Falsetti P, Conticini E, Bardelli M, Baldi C, Gentileschi S, Nicosia A, Al Khayyat SG, Cantarini L and Frediani B. Efficacy of intravenous neridronate in transient osteoporosis of the hip. Clin Exp Rheumatol 2022; 40: 1681-1685.","DOI":"10.55563\/clinexprheumatol\/vzknda"},{"key":"ref21","unstructured":"Chen TZ, Lu XJ, Wu DZ, Meng FF and Qin RJ. Efficacy of minimally invasive transforaminal lumbar interbody fusion plus cement-augmented pedicle screw fixation in the treatment of degenerative lumbar spine disease with osteoporosis in the elderly. Eur Rev Med Pharmacol Sci 2023; 27: 6573-6582."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1014847","DOI":"10.3389\/fnut.2022.1014847","article-title":"Causal effect of polyunsaturated fatty acids on bone mineral density and fracture","volume":"9","author":"Tao","year":"2022","unstructured":"Tao SS, Wang P, Wang XY, Yin KJ, Yang XK, Wang ZX, Wang DG and Pan HF. Causal effect of polyunsaturated fatty acids on bone mineral density and fracture. Front Nutr 2022; 9: 1014847.","journal-title":"Front Nutr"},{"key":"ref23","unstructured":"Cao Y, Qiu Y, Liu MX, Hu Y and Chen FW. MiR-29c-3p reduces bone loss in rats with diabetic osteoporosis via targeted regulation of Dvl2 expression. Eur Rev Med Pharmacol Sci 2021; 25: 636-642."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1007\/s00198-014-2755-9","article-title":"Management of osteoporosis of the oldest old","volume":"25","author":"Rizzoli","year":"2014","unstructured":"Rizzoli R, Branco J, Brandi ML, Boonen S, Bruyere O, Cacoub P, Cooper C, Diez-Perez A, Duder J, Fielding RA, Harvey NC, Hiligsmann M, Kanis JA, Petermans J, Ringe JD, Tsouderos Y, Weinman J and Reginster JY. Management of osteoporosis of the oldest old. Osteoporos Int 2014; 25: 2507-2529.","journal-title":"Osteoporos Int"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.maturitas.2018.11.010","article-title":"New therapeutic targets for osteoporosis","volume":"120","author":"Anagnostis","year":"2019","unstructured":"Anagnostis P, Gkekas NK, Potoupnis M, Kenanidis E, Tsiridis E and Goulis DG. New therapeutic targets for osteoporosis. Maturitas 2019; 120: 1-6.","journal-title":"Maturitas"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1186\/s13018-021-02821-8","article-title":"Global prevalence of osteoporosis among the world older adults: a comprehensive systematic review and meta-analysis","volume":"16","author":"Salari","year":"2021","unstructured":"Salari N, Darvishi N, Bartina Y, Larti M, Kiaei A, Hemmati M, Shohaimi S and Mohammadi M. Global prevalence of osteoporosis among the world older adults: a comprehensive systematic review and meta-analysis. J Orthop Surg Res 2021; 16: 669.","journal-title":"J Orthop Surg Res"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s40520-021-01817-y","article-title":"Pathophysiology and treatment of osteoporosis: challenges for clinical practice in older people","volume":"33","author":"Barnsley","year":"2021","unstructured":"Barnsley J, Buckland G, Chan PE, Ong A, Ramos AS, Baxter M, Laskou F, Dennison EM, Cooper C and Patel HP. Pathophysiology and treatment of osteoporosis: challenges for clinical practice in older people. Aging Clin Exp Res 2021; 33: 759-773.","journal-title":"Aging Clin Exp Res"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1007\/s00774-019-01009-9","article-title":"Eldecalcitol increases bone mineral density in Chinese osteoporotic patients without vitamin D or calcium supplementation","volume":"37","author":"Jiang","year":"2019","unstructured":"Jiang Y, Tang H, Ma X, Cheng Q, Lin H, Jin X, Zhang Z, Yu W, He S, Kobayashi T, Uehara S, Matsumoto T and Xia W. Eldecalcitol increases bone mineral density in Chinese osteoporotic patients without vitamin D or calcium supplementation. J Bone Miner Metab 2019; 37: 1036-1047.","journal-title":"J Bone Miner Metab"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1111\/os.12701","article-title":"Fall prevention and anti-osteoporosis in osteopenia patients of 80 years of age and older: a randomized controlled study","volume":"12","author":"Zhou","year":"2020","unstructured":"Zhou J, Liu B, Qin MZ and Liu JP. Fall prevention and anti-osteoporosis in osteopenia patients of 80 years of age and older: a randomized controlled study. Orthop Surg 2020; 12: 890-899.","journal-title":"Orthop Surg"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.jos.2020.10.017","article-title":"Impact of bone mineral density in reducing fracture risk in patients receiving alendronate plus alfacalcidol therapy","volume":"26","author":"Itoi","year":"2021","unstructured":"Itoi E, Uemura Y, Ohta H, Nakamura T, Fukunaga M, Orimo H and Shiraki M. Impact of bone mineral density in reducing fracture risk in patients receiving alendronate plus alfacalcidol therapy. J Orthop Sci 2021; 26: 1085-1093.","journal-title":"J Orthop Sci"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1111\/jog.13913","article-title":"Activated vitamin D3 formulations can be safely used as concomitant medication for prevention of denosumab-induced hypocalcemia in women with postmenopausal osteoporosis","volume":"45","author":"Saito","year":"2019","unstructured":"Saito S, Sugo Y, Tsuburai T, Kurasawa K, Nakamura T, Yoshikata H, Miyagi E and Sakakibara H. Activated vitamin D3 formulations can be safely used as concomitant medication for prevention of denosumab-induced hypocalcemia in women with postmenopausal osteoporosis. J Obstet Gynaecol Res 2019; 45: 908-914.","journal-title":"J Obstet Gynaecol Res"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s10067-020-05294-y","article-title":"The effect of calcium and vitamin D compounds on bone mineral density in patients undergoing glucocorticoid therapies: a network meta-analysis","volume":"40","author":"Deng","year":"2021","unstructured":"Deng J, Silver Z, Huang E, Zheng E, Kavanagh K and Panicker J. The effect of calcium and vitamin D compounds on bone mineral density in patients undergoing glucocorticoid therapies: a network meta-analysis. Clin Rheumatol 2021; 40: 725-734.","journal-title":"Clin Rheumatol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.afos.2021.05.003","article-title":"Comparative effect of eldecalcitol and alfacalcidol on bone microstructure: a preliminary report of secondary analysis of a prospective trial","volume":"7","author":"Ni","year":"2021","unstructured":"Ni X, Feng J, Jiang Y, Zhang L, Yu W, Wang O, Li M, Xing X, Matsumoto T and Xia W. Comparative effect of eldecalcitol and alfacalcidol on bone microstructure: a preliminary report of secondary analysis of a prospective trial. Osteoporos Sarcopenia 2021; 7: 47-53.","journal-title":"Osteoporos Sarcopenia"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"3236828","DOI":"10.1155\/2020\/3236828","article-title":"Calcitonin and bone physiology: in vitro, in vivo, and clinical investigations","volume":"2020","author":"Xie","year":"2020","unstructured":"Xie J, Guo J, Kanwal Z, Wu M, Lv X, Ibrahim NA, Li P, Buabeid MA, Arafa EA and Sun Q. Calcitonin and bone physiology: in vitro, in vivo, and clinical investigations. Int J Endocrinol 2020; 2020: 3236828.","journal-title":"Int J Endocrinol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s11914-020-00624-0","article-title":"The effects of calcitonin gene-related peptide on bone homeostasis and regeneration","volume":"18","author":"Xu","year":"2020","unstructured":"Xu J, Wang J, Chen X, Li Y, Mi J and Qin L. The effects of calcitonin gene-related peptide on bone homeostasis and regeneration. Curr Osteoporos Rep 2020; 18: 621-632.","journal-title":"Curr Osteoporos Rep"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1021\/acsami.2c19241","article-title":"Composite separable microneedles for transdermal delivery and controlled release of salmon calcitonin for osteoporosis therapy","volume":"15","author":"Li","year":"2023","unstructured":"Li Y, Ju XJ, Fu H, Zhou CH, Gao Y, Wang J, Xie R, Wang W, Liu Z and Chu LY. Composite separable microneedles for transdermal delivery and controlled release of salmon calcitonin for osteoporosis therapy. ACS Appl Mater Interfaces 2023; 15: 638-650.","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4140\/TCP.n.2019.109","article-title":"Osteoporosis medication use: a comparison of elderly females living in long-term care facilities versus community dwellers","volume":"34","author":"Loh","year":"2019","unstructured":"Loh FE, Stuart B, Sturpe D, Davidoff A, Onukwugha E and Hochberg M. Osteoporosis medication use: a comparison of elderly females living in long-term care facilities versus community dwellers. Sr Care Pharm 2019; 34: 109-126.","journal-title":"Sr Care Pharm"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00774-019-01077-x","article-title":"Minodronate combined with alfacalcidol versus alfacalcidol alone for glucocorticoid-induced osteoporosis: a multicenter, randomized, comparative study","volume":"38","author":"Soen","year":"2020","unstructured":"Soen S, Yamamoto K, Takeuchi T, Tanaka Y, Tanaka S, Ito M, Nakano T, Hagino H, Hirakawa A and Matsumoto T. Minodronate combined with alfacalcidol versus alfacalcidol alone for glucocorticoid-induced osteoporosis: a multicenter, randomized, comparative study. J Bone Miner Metab 2020; 38: 511-521.","journal-title":"J Bone Miner Metab"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jconrel.2023.01.071","article-title":"Yam-derived exosome-like nanovesicles stimulate osteoblast formation and prevent osteoporosis in mice","volume":"355","author":"Hwang","year":"2023","unstructured":"Hwang JH, Park YS, Kim HS, Kim DH, Lee SH, Lee CH, Lee SH, Kim JE, Lee S, Kim HM, Kim HW, Kim J, Seo W, Kwon HJ, Song BJ, Kim DK, Baek MC and Cho YE. Yam-derived exosome-like nanovesicles stimulate osteoblast formation and prevent osteoporosis in mice. J Control Release 2023; 355: 184-198.","journal-title":"J Control Release"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Vasikaran SD, Miura M, Pikner R, Bhattoa HP and Cavalier E; IOF-IFCC Joint Committee on Bone Metabolism (C-BM). Practical considerations for the clinical application of bone turnover markers in osteoporosis. Calcif Tissue Int 2023; 112: 148-157.","DOI":"10.1007\/s00223-021-00930-4"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Wang J, Zhu Q, Cao D, Peng Q, Zhang X, Li C, Zhang C, Zhou BO and Yue R. Bone marrow-derived IGF-1 orchestrates maintenance and regeneration of the adult skeleton. Proc Natl Acad Sci U S A 2023; 120: e2203779120.","DOI":"10.1073\/pnas.2203779120"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/16\/5\/ajtr0155033.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:53:26Z","timestamp":1766022806000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/16\/5\/ajtr0155033.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":42,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.62347\/zmal4724","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]}}}